Clinical Trial Update: Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 [Phase 4]

View source ↗

Summary

Phase 4 trial comparing hydroxychloroquine versus nitazoxanide in COVID-19 patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Hugo Mendieta Zeron | Conditions: Coronavirus Infection | Phase 4 | Status: TERMINATED